المؤلفون: Si‐Man Huang, Chao‐Ling Wan, Han‐Yu Cao, Yan‐Yan Li, Chong‐Sheng Qian, Hai‐Xia Zhou, Ming‐Zhu Xu, Xiao‐Hui Hu, Lan Dai, Hai‐Ping Dai, Sheng‐Li Xue

المصدر: Clinical Case Reports, Vol 11, Iss 12, Pp n/a-n/a (2023)

مصطلحات موضوعية: B‐ALL, CD22, inotuzumab ozogamicin, MRD positive, relapsed and refractory, Medicine, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2050-0904

URL الوصول: https://doaj.org/article/e00f4ab4696542c7889d7aed2a24ad24

المؤلفون: Huang SM; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology Soochow University Suzhou China.; Collaborative Innovation Center of Hematology Soochow University Suzhou China., Wan CL; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology Soochow University Suzhou China.; Collaborative Innovation Center of Hematology Soochow University Suzhou China., Cao HY; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology Soochow University Suzhou China.; Collaborative Innovation Center of Hematology Soochow University Suzhou China., Li YY; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology Soochow University Suzhou China.; Collaborative Innovation Center of Hematology Soochow University Suzhou China., Qian CS; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology Soochow University Suzhou China.; Collaborative Innovation Center of Hematology Soochow University Suzhou China., Zhou HX; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology Soochow University Suzhou China.; Collaborative Innovation Center of Hematology Soochow University Suzhou China., Xu MZ; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology Soochow University Suzhou China.; Collaborative Innovation Center of Hematology Soochow University Suzhou China., Hu XH; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology Soochow University Suzhou China.; Collaborative Innovation Center of Hematology Soochow University Suzhou China., Dai L; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology Soochow University Suzhou China.; Collaborative Innovation Center of Hematology Soochow University Suzhou China., Dai HP; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology Soochow University Suzhou China.; Collaborative Innovation Center of Hematology Soochow University Suzhou China., Xue SL; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology Soochow University Suzhou China.; Collaborative Innovation Center of Hematology Soochow University Suzhou China.

المصدر: Clinical case reports [Clin Case Rep] 2023 Dec 09; Vol. 11 (12), pp. e8289. Date of Electronic Publication: 2023 Dec 09 (Print Publication: 2023).

نوع المنشور: Case Reports

بيانات الدورية: Publisher: John Wiley & Sons Country of Publication: England NLM ID: 101620385 Publication Model: eCollection Cited Medium: Print ISSN: 2050-0904 (Print) Linking ISSN: 20500904 NLM ISO Abbreviation: Clin Case Rep Subsets: PubMed not MEDLINE